🇺🇸 FDA
Patent

US 8383132

Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 8383132 (Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use) held by The Regents of the University of California expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K2039/545, A61K2039/55522